Association of Adjuvant or Metastatic Setting With Discontinuation of Cancer Drugs in Clinical Trials
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.12327
Abstract: Key Points Question How does the percentage of patients who withdraw from adjuvant trials because of adverse events compare with patients who withdraw from metastatic trials for the same drug? Findings In this cross-sectional study,… read more here.
Keywords: setting discontinuation; adjuvant metastatic; metastatic setting; cancer drugs ... See more keywords